Sanofi Nigeria, a drug manufacturing
company, has restated its commitment to sound health care delivery
through the provision of affordable medicines that are tailored to the
needs of patients.
Speaking at the public presentation of
Aprovasc, a fixed-dose combination treatment for the management of
hypertension, the General Manager, Sanofi Nigeria-Ghana, Mr.
Abderrahmane Chakibi, said the product offers a wide range of treatment
options for patients with hypertension.
He also said that in order to support
the patients in the management of their disease, the drug firm has
opened diabetes and hypertension clinics in the country, in partnership
with health authorities.
“The first clinic was inaugurated at the Lagos State University Teaching Hospital on January 29, 2015,” he said.
He noted that while about 28.9 per cent
of the population is hypertensive, the majority of sufferers are not
aware of their condition; warning that by 2030, up to 39.1 million
people aged at least 20 years may live with hypertension if nothing is
done to reverse the trend.
Associate Professor of Medicine at the
University of Lagos, Dr. Amam Mbakwem, said people with uncontrolled
hypertension are exposed to heart attack and kidney failure.
